Post by StevieRay on Mar 31, 2014 19:22:42 GMT -5
I don't believe we have near the risk factors as Victoza did when it went before ADCOM/FDA Review.
cardiobrief.org/2010/01/25/fda-approves-liraglutide-victoza-for-type-2-diabetes/
"Last April the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee split down the middle and voted 6-6 on whether the cancer risk should stop the FDA from approving the drug. The committee also voted in an 8-5 vote that liraglutide did not have an excess cardiovascular risk."
Go to this section and you will find all the links for all the information on Victoza:
April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee
www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm126136.htm